LATEST NEWS

PHARMA

Pharma

Scholar Rock Reports First-Quarter Results as FDA Review of Apitegromab Advances

Life Sciences Times - 0
CAMBRIDGE, Mass. — Scholar Rock reported first-quarter financial results and said it is preparing for a potential U.S. launch of apitegromab, its investigational treatment...

Parabilis Medicines Adds Alan M. Sebulsky to Board of Directors

Ironwood Reports Strong First Quarter as LINZESS Sales Rise

Vertex Reaches German Reimbursement Agreement for CASGEVY

Vertex Reports First-Quarter Revenue Growth, Reiterates 2026 Outlook

Medtech

Real Estate

Real Estate

Corbus Pharmaceuticals Renews Norwood Lease as It Advances Cancer and Obesity Pipeline

Life Sciences Times - 0
NORWOOD, Mass. — Corbus Pharmaceuticals Holdings Inc. will continue operating from 500 River Ridge Drive in Norwood after renewing its 36,471-square-foot lease at the...

Thermo Fisher Opens Bioprocess Design Center in Massachusetts to Speed Biologics Development

Lightstone acquires Greater Boston life sciences campus for $68 million

Life Sciences

Museum of Science Raises Record $1.8 Million at Stars of STEM Gala

Life Sciences Times - 0
BOSTON — The Museum of Science raised a record $1.8 million at its annual Stars of STEM gala, drawing more than 500 leaders, innovators...

Charles River Laboratories Reports First-Quarter Revenue Growth

Life Sciences Times - 0
WILMINGTON, Mass. — Charles River Laboratories International, Inc. reported first-quarter revenue of $995.8 million, up 1.2% from $984.2 million in the same period last...

Clean Air Partners Urges Residents to Cut Backyard Air Pollution

Life Sciences Times - 0
WASHINGTON — Clean Air Partners is urging Baltimore-Washington residents to reduce hidden sources of backyard pollution as the region marks Air Quality Awareness Week...

Thermo Fisher to Sell Microbiology Unit to Astorg in $1.075 Billion Deal

Life Sciences Times - 0
WALTHAM, Mass. — Thermo Fisher Scientific Inc. has agreed to sell its microbiology business to private equity firm Astorg in a transaction valued at...

Veristat to Acquire Certara’s Regulatory and Medical Writing Unit in Expansion Move

Life Sciences Times - 0
SOUTHBOROUGH, Mass. — Veristat announced plans to acquire Certara’s Regulatory and Medical Writing business, a move aimed at expanding its capabilities in supporting drug...

Today's Headlines

Advertisment

LATEST ARTICLES

123...836Page 1 of 836

Most Popular

Load more

Recent Comments